Cristina Birzu

10PUBLICATIONS
65CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityDisease surveillanceMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 02, 2026
Medium-Term Cognitive Outcome in Patients With CNS Lymphomas Treated With Chimeric Antigen Receptor T-Cell Therapy.

|Aug 10, 2026
Parkinsonism as a Potential Neurologic Immune-Mediated Adverse Event of Immune Checkpoint Inhibitors.

|Feb 13, 2026
Clinical Features and Biomarkers Associated With Intensive Care-Dependent Refractory NMDAR Encephalitis: A Retrospective Cohort Study.

Iker Elosua-Bayes, Pauline Dumez, Marie Benaiteau

|Jul 18, 2025
Immune Checkpoint Inhibitors Trigger and Exacerbate Anti-CV2/CRMP5 Paraneoplastic Neurologic Syndromes.

Giulia Sofia Cereda, Macarena Villagrán-García, Antonio Farina

|Mar 27, 2025
Neurotoxicity in Patients With CNS Lymphomas Treated With CAR T-Cell Therapy: A Study From the French Oculo-Cerebral Lymphoma Network.

Hugo Hernández-Tost, Nicolas Weiss, Sylvain Choquet

|Mar 01, 2025
Anti-GAD Antibodies as an Etiology of Cerebral Cortical Encephalitis: 2 Case Reports.

Bruno Lemarchant, Cristina Birzu, Louis Cousyn

Pageof 2

Frequent Collaborators

8 joint publications

Dimitri Psimaras

6 joint publications

Bastien Joubert

5 joint publications

Jerome Honnorat

4 joint publications

Antonio Farina